IDH1 and glioblastoma: More importantly, nomograms based on age, MGMT promoter status, radiation therapy, IDH1 mutation status, and TMZ response-related score were found to be able to very accurately predict the individual survival probability of patients with GBM and, thus, provide guidance for adjuvant therapy following by neurosurgery.